Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc.

August 2, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 2, 2011 /- Hadasit Bio-Holdings, Ltd. - (OTCBB: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, and its subsidiary, BioMarCare...

Minutes From Negotiation Meeting on MDUFA III Reauthorization: July 15, 2011

August 2, 2011 8:30 am | by U.S. Food & Drug Administration | News | Comments

To provide context for FDA's proposed approach to mitigate program uncertainties and advance negotiations, FDA started by summarizing the status of where MDUFA reauthorization discussions stand. From January through April, FDA provided more data and...

Cantel Medical Acquires Byrne Medical, Inc., Substantially Increasing Its Presence in GI Endoscopy

August 2, 2011 6:48 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Aug. 2, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ), through its Minntech subsidiary, has acquired the business and substantially all of the assets of Byrne Medical, Inc.  Byrne Medical, privately-owned and based outside Houston, TX, designs, manufactures and sells...

Advertisement

UL Expands Presence in Medical Device Market With Acquisition of MDT

August 2, 2011 6:48 am | by Bio-Medicine.Org | News | Comments

NORTHBROOK, Ill. and OCHSENHAUSEN, Germany, Aug. 2, 2011 /- UL, a world leader in advancing safety, today announced that it has acquired mdt medical device testing GmbH (MDT) and md registration support Ltd. (MDRS).  These two entities, based in Ochsenhausen, Germany, will become...

Avanir Pharmaceuticals to Present at Two Investor Conferences in August

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Aug. 2, 2011 /- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced that company management will present an overview of the company at the following investor conferences in August. Canaccord Genuity Annual Growth Conference Location: Intercontinental Hotel,...

Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn., Aug. 2, 2011 /- Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS®) System to...

Siemens Partners with American Cancer Society to Make Strides Against Breast Cancer

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 2, 2011 /- Today, Siemens announced that it is partnering with the American Cancer Society (ACS) in support of its premier national event to fight breast cancer – Making Strides Against Breast Cancer. The company, a pioneer in the fields of industry, energy, and...

PRA Expert's Pulmonary Function Textbook Reissued

August 2, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 2, 2011 /- PRA, a leading Clinical Research Organization, announces that the third edition of respiratory care expert Jack Wanger's book, Pulmonary Function Testing: A Practical Approach , has recently been published by Jones & Bartlett Learning in Sudbury, MA. Mr....

Advertisement

Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society

August 2, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Aug. 2, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that new preclinical data evaluating the safety of DepoFoam® with DEPC (a novel excipient) will be presented in two podium sessions at the...

Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results

August 2, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 2, 2011 /- Techne Corporation's (NASDAQ: TECH ) financial results for the fourth quarter and fiscal year ended June 30, 2011 include the following highlights: Fourth quarter earnings grew 9.4% to $28.3 million or $.76 per diluted share.  Earnings for the quarter...

Henry Schein Reports Record Second Quarter Results

August 2, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Aug. 2, 2011 /- Henry Schein, Inc. (NASDAQ: HSIC ), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended June 25, 2011. Net sales for the second quarter of 2011 were $2.1...

Concord Medical to Announce Second Quarter 2011 Financial Results on August 16, 2011

August 2, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 2, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its unaudited...

BD Announces Results For 2011 Third Fiscal Quarter

August 2, 2011 4:48 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., Aug. 2, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the...

Advertisement

Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses

August 2, 2011 4:44 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO and WOODCLIFF LAKE, N.J., Aug. 2, 2011 /- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) and Eisai Inc. announced today the completion of a clinical study that measured lorcaserin concentrations in human cerebrospinal fluid (CSF) and plasma and related data analyses. The study was...

MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®

August 2, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 2, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and...

New IOF-ISCD review clarifies the use of FRAX in clinical practice

August 2, 2011 12:46 am | by International Osteoporosis Foundation | News | Comments

Details strengths and limitations of the tool, provides recommendations for using surrogate country models

Summary Information for: VITROS Immunodiagnostic Products Anti-HBe Reagent Pack, VITROS Immunodiagnostic Products Anti-HBe Calibrator, and VITROS Immunodiagnostic Products Ant...

August 1, 2011 9:32 pm | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for VITROS Immunodiagnostic Products Anti-HBe Reagent Pack, VITROS Immunodiagnostic Products Anti-HBe Calibrator, and VITROS Immunodiagnostic Products Anti-HBe Controls (P100001).

Nanofiber Regenerates Blood Vessels

August 1, 2011 2:45 pm | by Massachusetts Institute of Technology | News | Comments

A synthetic material may help to repair tissue after a heart attack, and aid transplants.

Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay for the Detection of C. difficile Including Hypervirulent Strains

August 1, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Aug. 1, 2011 /- Intelligent Medical Devices, Inc. (IMDx) today announced it has received CE-Mark for a high-throughput automated assay for the detection of C. difficile , including the A-B+ 1470 variant, as well as the NAP1 strain. The IMDx™ C. difficile assay for...

New Arrivals of Special Thermometers for Babies & Elderly

August 1, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Aug. 1, 2011 /PRNewswire-Asia/--In recent years, both people's need to be healthy and expense in health care keep increasing, while the improvement of their self-awareness and increase of economic conditions promotes the demand for healthcare products. Shenzhen Wuzhou...

A Quick, Cheap Diagnostic Test for HIV and Other Infections

August 1, 2011 11:41 am | by Massachusetts Institute of Technology | News | Comments

A simple microfluidics chip could improve health care in poor countries by making rapid diagnostic testing a reality.

Unapproved Emergency Birth Control Medicine Possibly in U.S. Distribution May Be Ineffective and Unsafe

August 1, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital. These products may be counterfeit versions of the "morning after pill" and may not be safe...

Global Health Ventures to Present Live, Online at RetailInvestorConferences.com on August 4th

August 1, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 1, 2011 /- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that Dr. Hassan Salari PhD, Chairman and CEO will be presenting at RetailInvestorConferences.com. DATE:  August 4, 2011 TIME:...

Upsher-Smith Laboratories Named Manufacturer of the Year by AmerisourceBergen Corporation

August 1, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., Aug. 1, 2011 /- Upsher-Smith Laboratories, Inc. announced today that it received the prestigious AmerisourceBergen  Manufacturer of the Year Award for branded pharmaceutical sales under $500 million at the annual National Healthcare Conference and Exposition...

Meaningful Use Certification Awarded to Press Ganey's Quality Performer(SM)

August 1, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

SOUTH BEND, Ind., Aug. 1, 2011 /- Press Ganey's Quality Performer - Hospital eMeasures attained electronic health record (EHR) clinical quality measures module certification on July 27, 2011. The Hospital eMeasures functionality within Quality Performer – a comprehensive clinical...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading